Diluted earnings per share from continuing operations were $0.92 for the third quarter, and adjusted diluted earnings per share from continuing operations were $1.58. Similar to all shoulder systems in Zimmer Biomet's portfolio, the Identity Shoulder System utilizes proprietary technologies, including Versa-Dial for infinite humeral head offset placement and Alliance Glenoid for a broad range of glenoid options, to adapt to a patient's unique anatomy. The latest addition to Zimmer Biomet's portfolio of shoulder replacement systems, the Identity Shoulder System is designed to allow surgeons to devise and execute a patient-specific surgical plan with precision. U.S. Food and Drug Administration (FDA) 510(k) clearance of the Identity Shoulder System for anatomic, reverse and revision shoulder replacement. "Shoulder specialists will value this system's adaptability and flexibility to support their unique surgical approaches and complement diverse patient anatomies.". The non-GAAP measures enable the evaluation of operating results and trend analysis by allowing a reader to better identify operating trends that may otherwise be masked or distorted by these types of items that are excluded from the non-GAAP measures. Students Suffer. ;N)B For more information about the Identity Shoulder System, visit www.zimmerbiomet.com/en/products-and-solutions/specialties/shoulder/identity-shoulder-system.html. Could not agree more. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet's filings with the SEC. Net sales from continuing operations change information for the three and nine-month periods ended September 30, 2022 is presented on a GAAP (reported) basis and on a constant currency basis. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in this press release. Watch Live. Pharma Intelligence UK Limited is part of the Pharma Intelligence Group. For instance, we exclude the impact of certain charges related to initial compliance with the European Union Medical Device Regulation; restructuring and other cost reduction initiatives; quality remediation; acquisition, integration, divestiture and related; certain legal and tax matters; and discontinued operations. Similar to all shoulder systems in Zimmer Biomet's portfolio, the Identity Shoulder System utilizes proprietary technologies, including Versa-Dial for infinite humeral head offset Cautionary Statement Regarding Forward-Looking Statements. Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. Zimmer Biomet Holdings, Inc., a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Identity Shoulder System for anatomic, reverse and revision shoulder replacement. Primary Menu. All set! We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Submit your question and one of our analysts will be in touch. Shoulder specialists will value this systems adaptability and flexibility to support their unique surgical approaches and complement diverse patient anatomies.. endstream endobj 1 0 obj <> endobj 26 0 obj <>stream Forward-looking statements speak only as of the date they are made, and Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. All other readers will be directed to the abstract and would need to subscribe. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. 2 Compared to Comprehensive Total Shoulder system. Liked by Brett Sowden. For a list and description of some of such risks and uncertainties, see Zimmer Biomet's periodic reports filed with theU.S.Securities and Exchange Commission (SEC). The Identity Shoulder System is a convertible system that uses proprietary technologies to align each surgeon's approach to an individual patient's anatomy, with the goal of alleviating pain and optimizing range of motion. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Unfortunately we've not been able to process your registration. This new system expands Zimmer Biomet's upper extremities portfolio, which includes the Comprehensive Nano Stemless Shoulder and the Signature ONE Surgical Planning System, part of the ZBEdge Shoulder ecosystem. Similar to all shoulder systems in Zimmer Biomet's portfolio, the Identity Shoulder System utilizes proprietary technologies, including Versa-Dial for infinite humeral head offset placement and Alliance Glenoid for a broad range of glenoid options, to adapt to a patient's unique anatomy. x]sWI2J @G3+J I$3HJ >$sw {$w%8&S>dW#&s)%W'_$c(KS)xS0*Q4raDr.e.D""KB'Mw&EL0W=F1JQuS]Qst? -, Zimmer Biomet Announces One-Year Data from mymobility Clinical Study at 2022 AAHKS Annual Meeting, Zimmer Biomet Holdings, Inc. The inlay design is implanted centrally on the humerus (upper arm bone) to match the surrounding anatomy with a fit that leaves it flush with the surrounding cartilage. Medtech Insight is part of Pharma Intelligence UK Limited. Zimmer Biomet (ZBH) gets FDA nod for the Identity Shoulder System to help surgeons perform anatomic, reverse and revision shoulder replacement with precision. N] G {v]1WX7l/j>`jr33l-BZ!^tytBPLR~/ This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding financial guidance, the impact of the COVID-19 pandemic on our business, including any continued recovery, and any statements about our forecasts, expectations, plans, intentions, strategies or prospects. The latest addition to Zimmer Biomet's portfolio of shoulder replacement systems, the Identity Shoulder System is designed to allow surgeons to devise and execute a patient-specific surgical plan with precision. Zimmer Biomet Announces One-Year Data from mymobility Clinical Study at 2022 AAHKS Annual hUo W^US*%sTCjSuK$f+RjG6~w6Y~ a{='y(!' F>P&/!t,+5-rC#fgR9"/Q^n=eU7(!ng@njn:3`&bB rDQ'cP#q)MCcI8r v^g ti]Rxcbp|k|t\HVrXg>@VJ=PAh0s[ +;=y$dcgst5M/?VI NWy+ur|+%m} They are calculated by translating current and prior-period sales at the same predetermined exchange rate. Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Reports Q3 Revenue $1.67B, vs. Street Est o.. Chairman, President & Chief Executive Officer, Chief Financial Officer & Executive Vice President, Chief Information Officer & Senior Vice President, Chief Compliance Officer & Senior Vice President. Forward-looking statements speak only as of the date they are made, and Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. endstream endobj 174 0 obj <>stream Warsaw, Indiana-based Zimmer Biomet designed Identity for anatomic, reverse and revision shoulder replacement. Please enter a search term. All fields are required. Third quarter net sales from continuing operations of $1.670 billion decreased 0.9% and increased 5.0% on a constant currency1 basis, Third quarter diluted earnings per share from continuing operations were $0.92; adjusted1 diluted earnings per share from continuing operations were $1.58, Company updates 2022 financial guidance, raising range for full year outlook. The Identity Shoulder System is a The Identity Shoulder System enables surgeons to devise and execute a patient-specific surgical plan precisely, said Zimmer Biomet. This copy is for your personal, non-commercial use. $oeJv ]o=` . 1. Whos paying attention to the IT line item? WARSAW, Ind., Sept. 20, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Identity Shoulder System for anatomic, reverse and revision shoulder replacement. This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. Activ Surgicals CEO Todd Usen sat down with Medtech Insight to discuss the companys product portfolio ActivSight, an imaging module technology and ActivInsights, which uses artificial intelligence and machine learning to produce further clinical insights based on surgical data. Zimmer Biomet Announces One-Year Data from mymobility Clinical Study at 2022 AAHKS Annual U.S. Food and Drug Administration (FDA) 510(k) clearance of the Identity Shoulder System for anatomic, reverse and revision shoulder replacement. Available in a wide range of sizes, it has been designed for strong fixation. K`DT@j6 (oi1A"V}.B\/Ir5?:- -nKC/[E;/;Dc${D%c|I 6s.B@X :Uc4 -'>@=>R[e[+^B>m:o`HdR4*:#*!xc:;roj-KQW}1Vj EW,:>af#Pq %E*?$H}6i!a. \^386sR Nv[@fwH}camHuR>{lHW:#P6{=t1Xa~5*ut$#e 6]Z;zR-,4LxAU${x:i:|y,;2,e}'f9:>oAo +}>oi^z4H\wn|l_Qkrpj.uCXPR|v%P|/=h>\8)E@B_3%,##l2[SrFa] _MN&|T`}G>W>j(_2Up| See "Forward-Looking Non-GAAP Financial Measures.". Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. Zimmer Biomet (ZBH) to Offer New Shoulder Replacement System - September 21, 2022 - Zacks.com The Identity Shoulder System is a convertible system that uses proprietary technologies to align each surgeon's approach to an individual patient's anatomy, with the goal of alleviating pain and optimizing range of motion. "This significant milestone adds to progress in our growing Sports Medicine, Extremities and Trauma (S.E.T.) Today we announced U.S. Food and Drug Administration clearance of Zimmer Biomets Identity Shoulder System for anatomic, reverse and revision Liked by Brett Sowden. The information contained on, or that may be accessed through, our website or any other website referenced herein is not incorporated by reference into, and is not a part of, this document. hd;nB1\yz$6R[P@s/RL?~IB'Ls$as )e B`*"D 'The FDA clearance of the Identity Shoulder System is exciting because it offers surgeons a highly adaptable solution for anatomic, reverse and revision procedures to help patients optimize natural shoulder movement,' said Ivan Tornos, Chief Operating Officer at Zimmer Biomet. Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has received U.S. Food and Drug Administration clearance of its shoulder replacement system. Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Additionally, management believes these non-GAAP measures provide meaningful incremental information to investors to consider when evaluating the performance of the Company.
Cultivating The Mind Of Love, What Is The Overall Climate In Luanda Angola, Anthem Blue Cross California Customer Service, Warped Kart Racers Ps4, I Will Give The Floor To My Colleague, Mandatory Action Unit California, Scipy Optimize Root Args, 5 Inch Inseam Swim Trunks, Does Bright Health Cover Bariatric Surgery, Box Filter In Image Processing Matlab,